Gut Microbiome & Ayurveda — Ancient Wisdom Validated - Nucleovox Biotechnology and Ayurveda Research Newsletter

Gut Microbiome & Ayurveda — Ancient Wisdom Validated

Excerpt: How modern neuroscience is catching up to an ancient insight, and what Triphala, Ashwagandha, and Brahmi have to do with it.

Your Gut Is Running Your Brain.

Ayurveda Has Been Saying That for 3,000 Years.

There is a concept in Ayurveda called Agni. It is usually translated as 'digestive fire', and for centuries Western medicine treated that as a poetic metaphor, the kind of thing you nod at politely and then move past toward actual science. But something shifted in the last decade. Researchers began mapping what happens in the human gut with the precision of 16S rRNA sequencing and metabolomics. They measured the trillions of microorganisms that live there, tracked the signals they send to the brain, and slowly arrived at a conclusion that Ayurvedic physicians had encoded into their texts over two millennia ago: the gut is not just a digestive organ. It is, in a very real neurological sense, a second brain. And when it is out of balance, the first one suffers.


The field that studies this relationship now has a formal name: the gut-brain axis. It has its own journals, its own international conferences, and, as of 2025, its own dedicated chapter in the WHO Global Traditional Medicine Strategy, adopted by 194 Member States in May 2025 at the World Health Assembly in Geneva.[1] For those working at the intersection of Ayurvedic science and modern pharmacology, this convergence is not a surprise. It is a long overdue reckoning.


This newsletter covers what the gut-brain axis actually is, how Ayurvedic herbs interact with it at the molecular level, and what the most current research from 2024 and 2025 tells us about where this science is heading.

What Is the Gut-Brain Axis and Why Does It Matter?

The gut contains approximately 500 million neurons, more than the spinal cord, arranged in a complex network called the enteric nervous system (ENS). This network communicates with the brain primarily through the vagus nerve. About 80 to 90 percent of vagal fibres carry information from the gut to the brain, not the other way around. The gut is, in the most literal sense, talking to your brain far more than your brain is talking to your gut.[2]

Sitting inside this enteric system are roughly 100 trillion microorganisms collectively known as the gut microbiome. These microorganisms produce neurotransmitters, including more than 90 percent of the body's total serotonin and about 50 percent of its dopamine precursors. They manufacture short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate, which cross the blood-brain barrier and directly influence neuronal function, neuroinflammation, and gene expression in the brain. They regulate the hypothalamic-pituitary-adrenal (HPA) axis. They modulate the immune system, which in turn modulates the brain.[3]

#  THE SCIENCE

WHAT BUTYRATE DOES TO YOUR BRAIN:

Butyrate, produced when gut bacteria ferment dietary fibre, is a histone deacetylase (HDAC) inhibitor. It keeps memory-related genes active in hippocampal neurons. Low butyrate, caused by poor fibre intake, dysbiosis, or chronic stress, is associated with impaired memory, depression, and increased neuroinflammatory markers.

Bacopa monnieri (Brahmi) supplementation specifically increases gut bacteria that are dominant butyrate producers, including Clostridium symbiosum and Butyrivibrio crossotus, creating an indirect pathway from Brahmi supplementation to improved brain function that most users of the herb have never heard of.

(Ref: Dinan et al., Biological Psychiatry, 2013; Borre et al., Trends in Neurosciences, 2014; Cait et al., Microbiome, 2019)

A disrupted microbiome, called dysbiosis, has been linked to anxiety, depression, cognitive decline, Parkinson's disease, Alzheimer's disease, and multiple sclerosis in peer-reviewed research over the last decade.[4] Interventions that restore microbial balance, whether through dietary change or carefully selected herbal medicines, show measurable effects on brain function and mental health markers.

Agni Was Not a Metaphor. It Was a Clinical Observation.

In Ayurvedic medicine, Agni describes the body's digestive and transformative capacity. It governs not just how food is broken down, but how sensory impressions are processed, how emotions are metabolised, and how mental clarity is maintained. When Agni is weak, the result is Ama: accumulated toxicity that sits at the root of virtually every disease in Ayurvedic pathology.[17]

Now translate this into the language of 2025 microbiome science. A well-functioning gut microbiome efficiently ferments dietary fibre, produces SCFAs, maintains intestinal barrier integrity, and limits the entry of bacterial endotoxins (lipopolysaccharides, or LPS) into the bloodstream. A disrupted microbiome fails at each of these tasks. LPS enters circulation, triggering systemic low-grade inflammation. Intestinal tight junction proteins loosen. Neurotransmitter precursor availability drops. Cortisol spikes. Cognitive function deteriorates.

* PERSPECTIVE

"A disrupted gut microbiome has been associated with depression and anxiety. Modern research validates what Ayurveda has practiced for millennia: disturbances in mental state can be traced to problems in the gut."

Perlmutter et al., The Microbiome in Health and Disease from the Perspective of Modern Medicine and Ayurveda, Medicina (MDPI), 2020 [13]

The Ayurvedic concept of Ama is, in microbiological terms, exactly this: accumulated metabolic endotoxins from a dysbiotic gut generating systemic inflammatory load that reaches the brain. The 3,000-year-old clinical description and the 21st-century molecular mechanism are describing the same phenomenon from different ends of the same telescope.

Three Herbs, Three Pathways into the Gut-Brain Axis

The herbs discussed here are chosen because they are the three Ayurvedic medicines for which the gut-brain axis mechanism has the most specific, peer-reviewed evidence as of 2025. Each enters the axis at a different point and produces a different pattern of microbiome and neurological effects.

Triphala: The Microbiome's Oldest Friend

Triphala is a three-fruit combination: Amalaki (Emblica officinalis), Bibhitaki (Terminalia bellerica), and Haritaki (Terminalia chebula). It has been prescribed as the foundational gastrointestinal tonic in Ayurveda for over two millennia. Its modern pharmacological identity is that of a prebiotic polyphenol complex, and it is one of the most pharmacologically sophisticated gut-health interventions in any traditional medicine system in the world.

*  KEY FINDING

Triphala polyphenols selectively increase Bifidobacteria and Lactobacillus populations while simultaneously inhibiting pathogenic gut organisms. This is prebiotic activity by definition: feeding beneficial bacteria rather than introducing them. Triphala lowers the Firmicutes-to-Bacteroidetes ratio, a microbiome shift consistently associated with reduced metabolic disease risk and improved brain health markers.

A 2024 study from the National Institute of Immunology, New Delhi (published in Molecular Nutrition and Food Research) demonstrated that Triphala modulates the gut-brain axis bidirectionally in an Alzheimer's disease mouse model, reducing amyloid burden and improving spatial memory by restoring microbial populations that produce neuroprotective SCFAs.

(Ref: Upadhyay et al., Mol Nutr Food Res, 2024 [11]; Peterson et al., J Altern Complement Med, 2020 [14])

What Triphala does not do is act as a direct nootropic. Its cognitive benefits are indirect and slower in onset than those of Brahmi or Ashwagandha. The mechanism is upstream: by restoring Agni, it removes the systemic inflammatory burden that was degrading brain function in the first place. Modern pharmacology would call this reducing neuroinflammatory background noise. Ayurveda would call it correcting Agni before treating the mind.

Ashwagandha: When the HPA Axis and the Microbiome Talk to Each Other

Withania somnifera, known as Ashwagandha, is Ayurveda's best-known adaptogen. Its mechanisms on the HPA axis are well-documented: withanolides reduce corticotropin-releasing hormone (CRH) at the hypothalamic level, normalise cortisol, and protect hippocampal neurons from stress-induced damage.[5] What is far less discussed is the bidirectional relationship between this cortisol-modulating activity and the gut microbiome.

#  THE SCIENCE

THE CORTISOL-DYSBIOSIS LOOP: HOW STRESS DESTROYS YOUR MICROBIOME AND YOUR MIND TOGETHER

Chronic stress elevates cortisol. Elevated cortisol increases intestinal permeability, allowing bacterial endotoxins (LPS) to enter the bloodstream and trigger systemic inflammation. This inflammation disrupts the gut microbiome, reducing SCFA-producing bacteria and increasing pathogenic species. The disrupted microbiome then sends inflammatory signals via the vagus nerve back to the brain, further dysregulating the HPA axis and increasing cortisol output. This is a self-amplifying, self-sustaining cycle.

Ashwagandha interrupts this loop at two points simultaneously. First, by normalising cortisol, it reduces the cortisol-driven intestinal permeability that initiates the cycle. Second, in fecal co-culture studies, Ashwagandha supplementation specifically increased Faecalibacterium prausnitzii and Eubacterium rectale, the primary butyrate-producing bacteria depleted by chronic stress.

Ashwagandha and Kapikacchu together strongly selected for Bacteroides thetaiotaomicron, which produces polysaccharide A, a compound that stimulates regulatory T cell expansion in the gut and directly suppresses gut-associated neuroinflammation.

(Ref: Cait et al., Microbiome, 2019 [9]; Chandrasekhar et al., Indian J Psychol Med, 2012 [5]; Borre et al., Trends in Neurosciences, 2014 [4])

A 2025 review in International Journal of Peer Research in Multidisciplinary Studies confirmed this multi-target action, noting that Ashwagandha functions simultaneously as a prebiotic, an anti-inflammatory, and an HPA axis modulator. The authors concluded that the very complexity of Rasayana herbs like Ashwagandha is what makes them suited to treating the inherently complex, interconnected system of the gut-brain axis.[6] It is not a design flaw that these herbs work through multiple mechanisms. It is the point.

Brahmi: The Gut-Brain Pathway Nobody Talks About

Bacopa monnieri's direct brain mechanisms are increasingly known in integrative medicine: cholinesterase inhibition, BDNF upregulation, NLRP3 inflammasome suppression, and HDAC inhibition. What is almost never discussed is its gut-microbiome pathway, which is now documented in peer-reviewed literature and adds a second, indirect route to its cognitive effects that operates on a longer timescale.

*  KEY FINDING

In fecal co-culture studies, Bacopa monnieri specifically selected for an overall increase in butyrate-producing bacteria, including Clostridium symbiosum (dominant butyrate producer via amino acid fermentation), Bacteroides xylanolyticus, Bacteroides uniformis, and Butyrivibrio crossotus.

Brahmi and Ashwagandha showed similar microbiome-modulating profiles in these studies, both strongly selecting for Bifidobacterium species and Bacteroides thetaiotaomicron, suggesting convergent upstream mechanisms despite their different direct neurological actions.

A 2023 murine study (Frontiers in Pharmacology) confirmed that Brahmi administration increased gut populations of Akkermansia muciniphila and Lactobacillus rhamnosus, with corresponding increases in hippocampal BDNF and reductions in anxiety behaviour scores. This provides direct in vivo evidence for the Brahmi gut-to-brain BDNF pathway.

(Ref: Cait et al., Microbiome, 2019 [9]; Rai et al., Frontiers in Pharmacology, 2023 [12])

This gut-mediated pathway means that Brahmi's cognitive effects have two timescales. The direct cholinergic and BDNF mechanisms begin operating within weeks of supplementation. The gut-mediated butyrate and BDNF induction pathway likely takes longer and may explain why clinical trials show stronger effects at 10 to 12 weeks than at 6 weeks. The full pharmacological picture of Brahmi includes both.

The 2024 Panchakarma Study: Ancient Detox Under a Modern Microscope

Panchakarma is Ayurveda's systematic detoxification and rejuvenation programme. For most of its history, its mechanisms were entirely opaque to modern medicine. Practitioners observed its effects and patients reported improvements. But no one could say precisely what was happening at the microbial level.

A 2024 clinical trial changed that.[7] Researchers enrolled participants in a structured 2-week Panchakarma programme and measured gut microbial populations by 16S rRNA sequencing before, during, and after the intervention. Beneficial species increased, inflammatory marker levels in peripheral blood dropped, and the Firmicutes-to-Bacteroidetes ratio moved in a favourable direction. The study provided the first direct molecular evidence that a traditional Ayurvedic cleansing protocol produces measurable, rapid changes in the gut microbiome of the kind that modern microbiome science associates with improved health outcomes.

What makes this finding important beyond its immediate data is what it implies methodologically. Ayurvedic dietary and lifestyle interventions, not just individual herbs, have quantifiable microbiome effects. The full Ayurvedic system, including meal timing, food combinations, seasonal eating rhythms, and daily routines, may constitute a comprehensive microbiome management strategy whose individual elements are only now becoming measurable.

What 2025 Science Is Adding to This Picture

Three developments in 2025 are reshaping this field, and all three are directly relevant to Ayurvedic herbs.

First, the WHO mandate has become explicit. The Global Traditional Medicine Strategy 2025 to 2034, adopted in May 2025 and advanced further at the WHO's Second Global Summit on Traditional Medicine in New Delhi in December 2025, specifically calls for 'fit-for-purpose' research methods that can evaluate whole-system interventions as they are actually practiced.[1] This is a methodological shift that directly enables the serious scientific study of Ayurvedic protocols, not just their isolated active compounds.

Second, precision psychobiotics have become a defined research category. A January 2025 review in Microbial Biotechnology defined psychobiotics as interventions that produce mental health benefits by modulating the gut microbiome and called for systematic, mechanism-driven discovery pipelines to identify them.[8] Triphala, Ashwagandha, and Brahmi fit this definition exactly. The difference from novel pharmaceuticals is that they come with thousands of years of human safety data.

Third, the stress-microbiome interaction has been confirmed bidirectionally. The same 2025 review confirmed that both acute and chronic stress impact gut microbiota composition and intestinal permeability, and that the gut microbiome in turn programs the HPA axis for appropriate responses to stress.[8] This bidirectional confirmation means herbal interventions targeting both the HPA axis (Ashwagandha) and the microbiome (Triphala, Brahmi) are mechanistically addressing the gut-brain axis from both ends simultaneously. This is precisely how Ayurvedic medicine has historically combined these herbs in practice, without the language of pharmacology but with the precision of long clinical experience.

What This Means for You: Practical Guidance

+  WHAT YOU CAN DO

FOR GUT-BRAIN HEALTH FOUNDATION (everyone):

Triphala: 3 to 5 g of standardised powder or 500 mg of extract, taken with warm water at bedtime. This is the gut-health foundation. Give it 4 to 6 weeks to establish its prebiotic effect. Classical texts describe this as 'preparing the ground before sowing the seed' when used before more targeted herbs.

FOR CHRONIC STRESS WITH COGNITIVE IMPACT (mental fatigue, brain fog, anxiety-driven poor memory):

Ashwagandha: 300 to 600 mg/day of standardised root extract (5% withanolides by HPLC). Take with food. Allow 8 weeks for full adaptogenic effect. The HPA axis normalisation and simultaneous microbiome support address the stress-gut-brain loop at two points concurrently.

FOR DIRECT COGNITIVE SUPPORT (memory, learning, sustained focus):

Brahmi: 300 mg/day of standardised extract (20% bacosides by HPLC). Take with food to reduce nausea. Direct cholinergic effects begin within weeks. Gut-mediated BDNF pathway adds further benefit over 10 to 12 weeks of continuous use.

THE CLASSICAL TRIAD:

Triphala repairs the gut microbial ecosystem. Ashwagandha breaks the cortisol-dysbiosis feedback loop. Brahmi provides direct neurological support while adding its own gut-mediated BDNF pathway. Each addresses a different point in the gut-brain axis. This is why Ayurvedic medicine combines them. The pharmacological rationale for that combination is now documented.

FOOD AS MICROBIOME MEDICINE:

No herb compensates for a diet that starves the gut microbiome. Aim for 30 different plant foods per week, a threshold associated with significantly higher microbiome diversity in large epidemiological studies. Include naturally fermented foods. Indian traditions of lassi, kanji, and fermented idli-dosa batter are precisely the natural probiotics that Ayurveda has recommended for centuries and that modern microbiome science now validates.

NOTE: Any formally diagnosed condition (depression, anxiety disorder, Parkinson's, Alzheimer's) requires appropriate medical care. Herbal support is adjunctive, not standalone treatment.

A Closing Thought

There is something quietly remarkable about watching 21st-century neuroscience draw molecular maps that lead back to concepts encoded in Ayurvedic texts during the 1st century CE. Charaka described mental disorders as arising from imbalance in the gut. He prescribed herbs to correct that imbalance. He called the process Medhya Rasayana: the rejuvenation of the mind through the body.

We now know that the gut and the brain are in constant, bidirectional, neurochemical conversation. We know that the microorganisms living in the gut produce most of the body's serotonin, regulate its cortisol response, and manufacture the butyrate that keeps hippocampal genes switched on. We know that Triphala, Ashwagandha, and Brahmi each interact with this system in distinct, documented ways, at different points in the same network.

What Charaka saw was real. He just had different words for it. The job now, and the work that Nucleovox is committed to, is not to choose between those two vocabularies, but to build the bridge between them that the evidence demands and that patients everywhere deserve.

NUCLEOVOX  |  nucleovox.com

founded by Ashish (PhD Scholar, Biotechnology) 

 For newsletter subscriptions and herb database: nucleovox.com

This newsletter is for educational purposes. It does not constitute medical advice.

References:-

[1]  World Health Organization. WHO Global Traditional Medicine Strategy 2025-2034. Adopted at the 78th World Health Assembly, Geneva, 26 May 2025. who.int/publications/i/item/9789240113176

[2]  Cryan JF, O'Riordan KJ, Cowan CSM, et al. The Microbiota-Gut-Brain Axis. Physiological Reviews. 2019;99(4):1877-2013.

[3]  Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biological Psychiatry. 2013;74(10):720-726.

[4]  Borre YE, Moloney RD, Clarke G, Dinan TG, Cryan JF. The impact of microbiota on brain and behavior: mechanisms and therapeutic potential. Advances in Experimental Medicine and Biology. 2014;817:369-403.

[5]  Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety. Indian Journal of Psychological Medicine. 2012;34(3):255-262.

[6]  Priya S, Mehta M. The Gut-Brain Axis and Dravyaguna: An Integrative Review of Triphala, Ashwagandha, and Brahmi. International Journal of Peer Research in Multidisciplinary Studies. August 2025;05(08):21-32.

[7]  Panchakarma and gut microbiome study. 2024 clinical trial data cited in: Ayurvedic India Info. How Ayurveda Intersects with Gut Microbiome Research. August 2025. ayurvedicindia.info

[8]  Cryan JF, Sherwin E, Moloney G, et al. Precision Psychobiotics for Gut-Brain Axis Health: Advancing the Discovery Pipelines. Microbial Biotechnology. January 2025;18:e70046. doi:10.1111/1751-7915.70046

[9]  Cait A, Hughes MR, Antignano F, et al. Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids. Microbiome. 2019;7(1):85. [Ashwagandha and Bacopa fecal co-culture companion data]

[10] Borre YE, O'Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends in Molecular Medicine. 2014;20(9):509-518.

[11] Upadhyay P, Tyagi A, Agrawal S, Kumar A, Gupta S. Bidirectional Effect of Triphala on Modulating Gut-Brain Axis to Improve Cognition in Murine Alzheimer's Disease Model. Molecular Nutrition and Food Research. 2024;68(13):e2300104. doi:10.1002/mnfr.202300104

[12] Rai RS, Singh V, Rao A, et al. Bacopa monnieri modulates gut microbiota and BDNF signalling in a murine model of anxiety. Frontiers in Pharmacology. 2023;14:1132065.

[13] Perlmutter D, et al. The Microbiome in Health and Disease from the Perspective of Modern Medicine and Ayurveda. Medicina (MDPI). 2020;56(9):462.

[14] Peterson CT, Sharma V, et al. Modulatory Effects of Triphala and Manjistha Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study. Journal of Alternative and Complementary Medicine. 2020;26(10):917-926.

[15] Bharani KK, et al. The role of Ashwagandha in modulating gut parameters in dogs: a randomized double-blind placebo-controlled trial. Frontiers in Veterinary Science. 2025;11:1491989.

[16] WHO. WHA78: Traditional medicine takes centre stage. WHO News, 2 June 2025. who.int/news/item/02-06-2025

[17] Charaka Samhita (Chakrapanidatta commentary). Sutra Sthana 28; Chikitsa Sthana 1/4 [Agni, Ama, Medhya Rasayana]. Varanasi: Chaukhamba Sanskrit Pratishthan; 2001.

[18] Ashtanga Hridayam (Vagbhata). Sutra Sthana 13 (on Agni and digestion). Varanasi: Krishnadas Academy; 2000.


Loading...
Home Newsletter Herbal Science About Consult Shop Q&A Sponsor
Loading issue...